Quantifying the Effect of Antiplatelet Therapy
Authors:
- 1 October 2006
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 105 (4) , 676-683
Abstract
Background: Antiplatelet therapy with aspirin and clopidogrel is known to confer protection against ischemic events. Increasing numbers of patients are presenting for surgery while taking these drugs. This may lead to an increase in perioperative blood loss, particularly in those who have a heightened response to the drugs. Identifying these patients preoperatively would allow us to plan appropriate management. Methods: The antiplatelet effect of aspirin and/or clopidogrel was measured using two point-of-care monitors: the platelet function analyzer (PFA-100; Dade, Miami, FL) and the modified thromboelastograph (mTEG; Haemoscope Corp., Niles, IL). This was compared with optical light transmission aggregometry. Results: All people taking aspirin displayed a definitive aspirin effect on aggregometry (n = 20). Ninety percent of these were identified by modified thromboelastography (n = 18). Seventy percent were identified by the platelet function analyzer (n = 14). Fifty percent of people taking clopidogrel displayed a definitive response to the drug on aggregometry. Seventy percent of these were identified on modified thromboelastography (n = 7). None were identified by the platelet function analyzer. There was good agreement between the results of the aggregometry and modified thromboelastography in clopidogrel patients (kappa = 0.81). Conclusion: The search for a point-of-care monitor of platelet function has been the focus of much research. This study has shown that the modified thromboelastograph can be used for monitoring the effect of clopidogrel as well as aspirin. It potentially has a wide scope to be used for the monitoring of effectiveness of therapy as well as a possible predictor of perioperative bleeding.Keywords
This publication has 41 references indexed in Scilit:
- Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrelBMC Cardiovascular Disorders, 2003
- Monitoring Aspirin 1 00 mg and Clopidogrel 75 mg Therapy with the PFA-1 00 Device in Patients with Peripheral Arterial DiseaseVascular and Endovascular Surgery, 2003
- Editorial IBritish Journal of Anaesthesia, 2002
- Effect of clopidogrel on bleeding after coronary artery bypass surgeryCritical Care Medicine, 2001
- Aspirin Does Not Increase Allogeneic Blood Transfusion in Reoperative Coronary Artery SurgeryAnesthesia & Analgesia, 1996
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss — a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable anginaEuropean Journal of Cardio-Thoracic Surgery, 1994
- Effect of ticlopidine on blood loss, platelet turnover and platelet deposition on prosthetic surfaces in patients undergoing aorto-femoral bypass graftingThrombosis Research, 1991
- The Bleeding Time Response to Aspirin: Identifying the HyperresponderAmerican Journal of Clinical Pathology, 1990